Factors influencing Frey syndrome after parotidectomy with acellular dermal matrix
- PMID: 38576730
- PMCID: PMC10989425
- DOI: 10.12998/wjcc.v12.i9.1578
Factors influencing Frey syndrome after parotidectomy with acellular dermal matrix
Abstract
Background: Frey syndrome, also known as ototemporal nerve syndrome or gustatory sweating syndrome, is one of the most common complications of parotid gland surgery. This condition is characterized by abnormal sensations in the facial skin accompanied by episodes of flushing and sweating triggered by cognitive processes, visual stimuli, or eating.
Aim: To investigate the preventive effect of acellular dermal matrix (ADM) on Frey syndrome after parotid tumor resection and analyzed the effects of Frey syndrome across various surgical methods and other factors involved in parotid tumor resection.
Methods: Retrospective data from 82 patients were analyzed to assess the correlation between sex, age, resection sample size, operation time, operation mode, ADM usage, and occurrence of postoperative Frey syndrome.
Results: Among the 82 patients, the incidence of Frey syndrome was 56.1%. There were no significant differences in sex, age, or operation time between the two groups (P > 0.05). However, there was a significant difference between ADM implantation and occurrence of Frey syndrome (P < 0.05). ADM application could reduce the variation in the incidence of Frey syndrome across different operation modes.
Conclusion: ADM can effectively prevent Frey syndrome and delay its onset.
Keywords: Acellular allogenic dermal matrix; Acellular dermal matrix; Frey syndrome; Parotid gland tumor.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflict-of-interest.
Figures



Similar articles
-
[Clinical application of acellular dermal matrix to prevent gustatory sweating syndrome].Zhonghua Kou Qiang Yi Xue Za Zhi. 2007 Sep;42(9):570-1. Zhonghua Kou Qiang Yi Xue Za Zhi. 2007. PMID: 18070440 Clinical Trial. Chinese.
-
Acellular dermal matrix for prevention of Frey's syndrome after superficial parotidectomy of benign tumors.Am J Otolaryngol. 2021 Mar-Apr;42(2):102893. doi: 10.1016/j.amjoto.2020.102893. Epub 2021 Jan 4. Am J Otolaryngol. 2021. PMID: 33445038
-
[Analysis of predictors for Frey syndrome after parotidectomy].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Sep;33(9):854-857. doi: 10.13201/j.issn.1001-1781.2019.09.014. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31446704 Chinese.
-
Graft interposition for preventing Frey's syndrome in patients undergoing parotidectomy.Cochrane Database Syst Rev. 2019 Oct 3;10(10):CD012323. doi: 10.1002/14651858.CD012323.pub2. Cochrane Database Syst Rev. 2019. PMID: 31578708 Free PMC article. Review.
-
Systematic evaluation on the use of acellular dermis matrix graft in prevention Frey syndrome after parotid neoplasm surgery.J Craniofac Surg. 2013 Sep;24(5):1526-9. doi: 10.1097/SCS.0b013e31828dcdb3. J Craniofac Surg. 2013. PMID: 24036719 Review.
Cited by
-
Acellular dermal matrices in reconstructive surgery; history, current implications and future perspectives for surgeons.World J Clin Cases. 2024 Dec 16;12(35):6791-6807. doi: 10.12998/wjcc.v12.i35.6791. World J Clin Cases. 2024. PMID: 39687641 Free PMC article. Review.
References
-
- Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Acta Otolaryngol. 2006;126:1104–1109. - PubMed
-
- Linder TE, Huber A, Schmid S. Frey's syndrome after parotidectomy: a retrospective and prospective analysis. Laryngoscope. 1997;107:1496–1501. - PubMed
LinkOut - more resources
Full Text Sources